These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 23432206)

  • 1. Flow cytometry thresholds of myeloperoxidase detection to discriminate between acute lymphoblastic or myeloblastic leukaemia.
    Guy J; Antony-Debré I; Benayoun E; Arnoux I; Fossat C; Le Garff-Tavernier M; Raimbault A; Imbert M; Maynadié M; Lacombe F; Béné MC; Wagner-Ballon O;
    Br J Haematol; 2013 May; 161(4):551-5. PubMed ID: 23432206
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of peroxidase activity by alpha-naphthol/pyronine staining compared with benzidine staining in 101 acute leukemia cases.
    Latger-Cannard V; Bardet V; Malet M; Lagrange M; Empereur F; Fenneteau O
    Lab Hematol; 2010 Dec; 16(4):76-82. PubMed ID: 21097443
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of myeloperoxidase activity in primary leukemic cells by an enhanced chemiluminescent assay for differentiation between acute lymphoblastic and non-lymphoblastic leukemia.
    Tan S; Wang G; Peng M; Zhang X; Shen G; Jiang J; Chen F
    Clin Chim Acta; 2009 May; 403(1-2):216-8. PubMed ID: 19298796
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of myeloperoxidase detection by flow cytometry using two different clones of monoclonal antibodies.
    Leong CF; Kalaichelvi AV; Cheong SK; Hamidah NH; Rahman J; Sivagengei K
    Malays J Pathol; 2004 Dec; 26(2):111-6. PubMed ID: 16329563
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of myeloperoxidase by flow cytometry in acute lymphoblastic leukaemias with BCR-ABL gene rearrangement.
    Sánchez J; Serrano J; García-Castellano JM; Madrigal E; Torres A
    Leukemia; 2001 Oct; 15(10):1671-2. PubMed ID: 11587232
    [No Abstract]   [Full Text] [Related]  

  • 6. Monoclonal antibody anti-MPO is useful in recognizing minimally differentiated acute myeloid leukaemia.
    Praxedes MK; De Oliveira LZ; Pereira Wda V; Quintana IZ; Tabak DG; De Oliveira MS
    Leuk Lymphoma; 1994 Jan; 12(3-4):233-9. PubMed ID: 8167554
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The ultrastructure of hybrid acute leukemia: a study of 15 cases.
    Ru YX; Wang HJ; Yang BX; Liu JH; Li ZQ; Li CW; Wang JX; Mi YC
    Ultrastruct Pathol; 2005; 29(5):341-7. PubMed ID: 16257860
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Immunophenotyping in acute leukemia: detection of minimal residual disease].
    Pálóczi K; Nahajevszky S; Jakab K; Regéczy N; Gopcsa L; László E; Földi J
    Orv Hetil; 2000 Nov; 141(46):2487-92. PubMed ID: 11126681
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute lymphoblastic leukemia with myeloperoxidase activity.
    Wright S; Chucrallah A; Chong YY; Kantarjian H; Keating M; Albitar M
    Am J Hematol; 1996 Feb; 51(2):147-51. PubMed ID: 8579056
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative analysis of different permeabilization methods for the flow cytometry measurement of cytoplasmic myeloperoxidase and lysozyme in normal and leukemic cells.
    Lanza F; Latorraca A; Moretti S; Castagnari B; Ferrari L; Castoldi G
    Cytometry; 1997 Jun; 30(3):134-44. PubMed ID: 9222099
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intracytoplasmic detection of TCL1--but not ILT7-by flow cytometry is useful for blastic plasmacytoid dendritic cell leukemia diagnosis.
    Angelot-Delettre F; Biichle S; Ferrand C; Seilles E; Gaugler B; Harrivel V; Rosenthal-Allieri MA; Deconinck E; Saas P; Garnache-Ottou F
    Cytometry A; 2012 Aug; 81(8):718-24. PubMed ID: 22674796
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Minimal residual disease assessment in childhood acute lymphoblastic leukaemia: a Swedish multi-centre study comparing real-time polymerase chain reaction and multicolour flow cytometry.
    Thörn I; Forestier E; Botling J; Thuresson B; Wasslavik C; Björklund E; Li A; Lindström-Eriksson E; Malec M; Grönlund E; Torikka K; Heldrup J; Abrahamsson J; Behrendtz M; Söderhäll S; Jacobsson S; Olofsson T; Porwit A; Lönnerholm G; Rosenquist R; Sundström C
    Br J Haematol; 2011 Mar; 152(6):743-53. PubMed ID: 21250970
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Flow cytometry with or without cytochemistry for the diagnosis of acute leukemias?
    Kheiri SA; MacKerrell T; Bonagura VR; Fuchs A; Billett HH
    Cytometry; 1998 Apr; 34(2):82-6. PubMed ID: 9579605
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comprehensive flow cytometry phenotype in acute leukemia at diagnosis and at relapse.
    Li X; Du W; Liu W; Li X; Li H; Huang SA
    APMIS; 2010 May; 118(5):353-9. PubMed ID: 20477810
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of myeloperoxidase mRNA as a marker for myeloid lineage in acute leukemias.
    Crisan D; David D; DiCarlo R
    Arch Pathol Lab Med; 1996 Sep; 120(9):828-34. PubMed ID: 9140287
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of myeloperoxidase mRNA by leukemic cells from childhood acute lymphoblastic leukemia.
    Zhou M; Findley HW; Zaki SR; Little F; Coffield LM; Ragab AH
    Leukemia; 1993 Aug; 7(8):1180-3. PubMed ID: 8394481
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimizing antibody panels for efficient and cost-effective flow cytometric diagnosis of acute leukemia.
    Haycocks NG; Lawrence L; Cain JW; Zhao XF
    Cytometry B Clin Cytom; 2011; 80(4):221-9. PubMed ID: 21298777
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased activity of histone deacetylases in childhood acute lymphoblastic leukaemia and acute myeloid leukaemia: support for histone deacetylase inhibitors as antileukaemic agents.
    Sonnemann J; Gruhn B; Wittig S; Becker S; Beck JF
    Br J Haematol; 2012 Sep; 158(5):664-6. PubMed ID: 22686282
    [No Abstract]   [Full Text] [Related]  

  • 19. [Study of antigenic profile of blasts in acute lymphoblastic leukemia: flow cytometric analysis of 152 cases].
    Jmili NB; Souguir S; Yacoub S; Khelif A; Kortas M
    Ann Biol Clin (Paris); 2009; 67(5):543-51. PubMed ID: 19789126
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of polyclonal anti-myeloperoxidase antibody in myeloid lineage determination.
    Karnik MP; Nair CN; Zingde SM; Gothoskar BP; Zachariah L; Barbhaya S; Advani SH
    Indian J Med Res; 1994 Dec; 100():272-6. PubMed ID: 7829166
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.